Optimizing the effective doses of mitomycin C, 5-fluorouracil, and their combination on cultivated basal cell carcinoma

Sahar Balagholi¹; Maryam Aletaha²; Mozhgan Rezaei Kanavi³; Samira Karami³; Rasul Dabbaghi³; Parisa Ashtar Nakhaie²

DOI: 10.5935/0004-2749.20210049

1. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3. Ocular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Corresponding author

Mozhgan Rezaei Kanavi
E-mail: [email protected] & [email protected]

Funding: This study received no specific financial support.

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.

Print PDF English

How to cite this article:

Balagholi S, Aletaha M, Kanavi MR, Karami S, Dabbaghi R, Nakhaie PA. Otimização da dose efetiva da mitomicina C, do 5fluorouracil e da combinação de ambos em culturas de células de carcinoma basocelular. Arq. Bras. Oftalmol. 2021;84(5):. 10.5935/0004-2749.20210049

Export citation